» Authors » Fabienne Huber

Fabienne Huber

Explore the profile of Fabienne Huber including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 75
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bitos K, Kuehne T, Latshang T, Aeschbacher S, Huber F, Flueck D, et al.
Int J Chron Obstruct Pulmon Dis . 2023 Aug; 18:1753-1762. PMID: 37608834
Background: Amongst the millions of travelers to high altitude worldwide are many with chronic obstructive pulmonary disease (COPD), but data regarding the effects of acute exposure to altitude on exercise...
2.
Meszaros M, Latshang T, Aeschbacher S, Huber F, Flueck D, Lichtblau M, et al.
Int J Chron Obstruct Pulmon Dis . 2022 Jan; 16:3503-3512. PMID: 34992358
Purpose: Patients with chronic obstructive pulmonary disease (COPD) are particularly vulnerable to hypoxia-induced autonomic dysregulation. Hypoxemia is marked during sleep. In COPD, altitude exposure is associated with an increase in...
3.
Huber F, Lautenschlager S
Praxis (Bern 1994) . 2021 Oct; 110(14):787-788. PMID: 34702055
CME Dermatology 24/Answers: Porokeratosis Porokeratoses are a heterogeneous group of cornification disorders with the characteristic histological feature of the cornoid lamellae in the area of the marginal ridge. It is...
4.
Gutweniger S, Latshang T, Aeschbacher S, Huber F, Flueck D, Lichtblau M, et al.
Sci Rep . 2021 Oct; 11(1):20355. PMID: 34645842
This trial evaluates whether nocturnal oxygen therapy (NOT) during a stay at 2048 m improves altitude-induced exercise intolerance in lowlanders with chronic obstructive pulmonary disease (COPD). 32 lowlanders with moderate...
5.
Huber F, Lautenschlager S
Praxis (Bern 1994) . 2021 Sep; 110(13):709-716. PMID: 34583541
CME Dermatology 24: Porokeratosis Porokeratoses are a heterogeneous group of cornification disorders with the characteristic histological feature of the cornoid lamellae in the area of the marginal ridge. It is...
6.
Lichtblau M, Latshang T, Aeschbacher S, Huber F, Scheiwiller P, Ulrich S, et al.
Front Physiol . 2021 Jul; 12:689863. PMID: 34305642
Introduction: We investigated whether nocturnal oxygen therapy (NOT) mitigates the increase of pulmonary artery pressure in patients during daytime with chronic obstructive pulmonary disease (COPD) traveling to altitude. Methods: Patients...
7.
Bisang M, Latshang T, Aeschbacher S, Huber F, Flueck D, Lichtblau M, et al.
Front Med (Lausanne) . 2021 Mar; 8:557369. PMID: 33732710
Chronic obstructive pulmonary disease (COPD) is associated with cardiovascular disease. We investigated whether sleeping at altitude increases nocturnal heart rate (HR) and other markers of cardiovascular risk or arrhythmias in...
8.
Lichtblau M, Saxer S, Latshang T, Aeschbacher S, Huber F, Scheiwiller P, et al.
Front Med (Lausanne) . 2020 Sep; 7:502. PMID: 32984379
Stable patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension (PH) wish to undergo altitude sojourns or air travel but fear disease worsening. This pilot study investigates health effects of...
9.
Tan L, Latshang T, Aeschbacher S, Huber F, Flueck D, Lichtblau M, et al.
JAMA Netw Open . 2020 Jun; 3(6):e207940. PMID: 32568400
Importance: There are no established measures to prevent nocturnal breathing disturbances and other altitude-related adverse health effects (ARAHEs) among lowlanders with chronic obstructive pulmonary disease (COPD) traveling to high altitude....
10.
Eisele G, Roelcke U, Conen K, Huber F, Weiss T, Hofer S, et al.
Neurooncol Pract . 2019 Aug; 6(3):237-244. PMID: 31386047
Background: During the course of disease, most glioma patients learn that there is no cure for their tumor. It is therefore not uncommon for patients or caregivers to seek complementary...